Delivery Order SPE2DB20D7066-SPE2DB26FC1MF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,318.52 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and reflects the agency's ongoing pharmaceutical supply needs for military healthcare operations. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,603.96 on July 29, 2025, for the supply of Remicade 100 mg vials, with a completion date of July 30, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $23,484.87 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 12, 2025. This firm fixed price contract, awarded on August 11, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $15,359.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of September 22, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor and represents a continuation of AmerisourceBergen's role as a critical supplier of pharmaceutical products to the federal healthcare system. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $21,183.76 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This firm fixed-price contract, awarded on September 4, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Remicade 100 mg vials, with a contract ceiling value of $27,685.64 and an ultimate completion date of July 30, 2025. This award is a firm fixed-price delivery order issued under a competitively awarded, non-set-aside procurement. The order represents a child contract action under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $26,992.64 firm fixed price delivery order for 100 mg vials of Remicade, a pharmaceutical product used to treat inflammatory conditions. This non-set-aside contract was awarded competitively on September 19, 2025, with an ultimate completion date of September 22, 2025, and represents a child order under a larger contract vehicle. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,495.88 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This competitively awarded, firm fixed-price contract was executed on October 20, 2025, with an ultimate completion date of October 21, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $10,024.40 firm fixed price delivery order is for the supply of Remicade 100 mg vials, a pharmaceutical product. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,967.93 by the Defense Logistics Agency (DLA) on September 22, 2025, for the supply of Remicade 100 mg vials. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and is executed as a child contract under...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB26FC1MFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials with a ceiling value of $5,012.00. This competitive award, issued on October 30, 2025, utilizes firm fixed pricing and is scheduled for completion by October 31, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and serves as a critical vendor for federal medical procurement needs supporting military and veteran healthcare systems. The company's extensive portfolio with the Defense Logistics Agency encompasses a wide range of pharmaceutical products, medical supplies, and specialized healthcare commodities across multiple therapeutic domains. This award was not set-aside and was competitively awarded, demonstrating the contractor's capability to meet federal procurement requirements through open competition alongside other qualified vendors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 10/30/25 |